superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2009-09-30
- Valid until
- 2010-03-31
- Published
- 2010-10-28
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 117,471,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Regeneron Pharmaceuticals quarterly research and development: 105,434,000 United States dollar", as of 2009-09-30 (until 2010-03-31). Claim clm_BF74EFFD510C, https://asof.is/claim/clm_BF74EFFD510C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm.
APA
AsOf. (2009). Regeneron Pharmaceuticals quarterly research and development: 105,434,000 United States dollar (as of 2009-09-30 (until 2010-03-31)) [Record clm_BF74EFFD510C]. Retrieved November 9, 2026, from https://asof.is/claim/clm_BF74EFFD510C (source: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm)
BibTeX
@misc{asof_clm_BF74EFFD510C,
author = {AsOf},
title = {Regeneron Pharmaceuticals quarterly research and development: 105,434,000 United States dollar},
year = {2009},
howpublished = {\url{https://asof.is/claim/clm_BF74EFFD510C}},
note = {Claim clm\_BF74EFFD510C, as of 2009-09-30 (until 2010-03-31); source: https://www.sec.gov/Archives/edgar/data/872589/000120677410002228/0001206774-10-002228-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_BF74EFFD510C.md/v1/claims/clm_BF74EFFD510Csubmit a correction